In patients with MDS, SF3B1 mutations are prevalent (approximately 25 % in all MDS cases) and occurring in approximately 85 % of cases in a form of MDS (refractory anemia with ringed sideroblasts) [32], with K700E the most frequently observed mutation. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.